These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 365085)

  • 1. Synergistic activity of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against Escherichia coli and Klebsiella pneumoniae.
    Paisley JW; Washington JA
    Antimicrob Agents Chemother; 1978 Nov; 14(5):656-8. PubMed ID: 365085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to antibiotics in clinical isolates of Klebsiella pneumoniae.
    O'Brien TF; Mayer KH; Hopkins JD; Farrell JJ; Chao L; Kent RL
    Infect Control; 1985 Feb; 6(2):64-7. PubMed ID: 3882592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 5. [Post-antibiotic effect in the treatment of infections in neutropenic patients].
    Bermudez LE
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(2):76-9. PubMed ID: 3105033
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.
    Parsley TL; Provonchee RB; Glicksman C; Zinner SH
    Antimicrob Agents Chemother; 1977 Sep; 12(3):349-52. PubMed ID: 410362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.
    Amyes SG
    Antimicrob Agents Chemother; 1982 Feb; 21(2):288-93. PubMed ID: 7041815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in
    Cusini A; Herren D; Bütikofer L; Plüss-Suard C; Kronenberg A; Marschall J
    Antimicrob Resist Infect Control; 2018; 7():89. PubMed ID: 30069305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subminimal inhibitory concentrations of gentamicin, penicillin, trimethoprim-sulfamethoxazole on adherence of uropathogenic Escherichia coli strains.
    Baskin H; Dogan Y; Hakki BI; Yulug N
    J Chemother; 2002 Apr; 14(2):161-5. PubMed ID: 12017371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the effect of antimicrobics in combination against Listeria monocytogenes.
    Meyer RD; Liu S
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):199-206. PubMed ID: 3105948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
    Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
    J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leucocyte function.
    Emmanouilides CE; Lianou PE; Bassaris HP; Papavassiliou JT
    J Antimicrob Chemother; 1990 Dec; 26(6):803-12. PubMed ID: 2081720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synergism of ciprofloxacin with beta-lactam antibiotics, gentamicin, minocycline and pipemidic acid].
    Dickgiesser N; in der Stroth S; Wundt W
    Infection; 1986; 14(2):82-5. PubMed ID: 2940188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.
    Thorén A
    Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):265-8. PubMed ID: 6258383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial action of trimethoprim-sulfamethoxazole.
    Gallien R
    J Infect Dis; 1973 Nov; 128():Suppl:486-97 p. PubMed ID: 4202206
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis.
    Stevens DA; Vo PT
    Antimicrob Agents Chemother; 1982 May; 21(5):852-4. PubMed ID: 7103462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.